APP and Alzheimer disease: In the amyloidogenic pathway, the amyloid precursor protein (APP), a transmembrane protein, undergoes proteolytic cleavage by β- and γ-secretases, resulting in the generation of Aβ peptides.8 Therefore, targeting β-secretase (BACE-1) inhibition presents a promising therapeutic strategy for preventing AD.